Investigation of association between the TRAF family genes and RA susceptibility

Objective: The tumour necrosis factor (TNF) receptor-associated factor (TRAF) family is important in activating multiple inflammatory and immune related processes induced by cytokines such as TNFα and interleukin-1. These genes therefore represent strong candidate susceptibility factors for rheumatoid arthritis (RA). A study was undertaken to investigate the association between single nucleotide polymorphisms (SNPs) spanning six TRAF genes and RA in a British population. Methods: Twenty-three haplotype tagging (ht) SNPs and 26 random SNPs spanning the six TRAF genes were initially tested for association in a cohort of 351 unrelated patients with RA and 368 controls. Any SNPs demonstrating an association were genotyped in further samples. Sequenom MassARRAY technology was preferentially used for genotyping. Both single point and haplotypic analyses were performed. Results: Forty-four SNPs were successfully genotyped and conformed to Hardy-Weinberg expectation. A single SNP, rs7514863, mapping upstream of the TRAF5 gene and affecting a putative transcription factor binding site, demonstrated a significant association across the entire cohort of 1273 cases with RA compared with 2463 healthy controls (OR for minor T allele 1.2 (95% CI 1.06 to 1.36), p = 0.005). The association was stronger in the subgroup carrying at least one copy of the shared epitope alleles (OR 1.43 (95% CI 1.18 to 1.73), p = 0.0003). Conclusion: These findings provide evidence for the association of an SNP upstream of a strong candidate RA susceptibility gene, TRAF5, in a large cohort of patients and controls. Further association and functional studies are required to investigate the role of this variant, or one in linkage disequilibrium with it, in RA disease causation.

[1]  Annette Lee,et al.  High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33 , 2006, Genes and Immunity.

[2]  F. Breedveld,et al.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[3]  T. Lindsten,et al.  Tumor Necrosis Factor Receptor (TNFR)-associated Factor 5 Is a Critical Intermediate of Costimulatory Signaling Pathways Triggered by Glucocorticoid-induced TNFR in T Cells* , 2006, Journal of Biological Chemistry.

[4]  C. Power,et al.  Cohort profile: 1958 British birth cohort (National Child Development Study). , 2006, International journal of epidemiology.

[5]  C. Rudd,et al.  T-cell signalling and immune system disorders , 2005, Expert Reviews in Molecular Medicine.

[6]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[7]  M. McDermott,et al.  the tumour necrosis factor receptor-associated periodic syndrome: current concepts , 2005, Expert Reviews in Molecular Medicine.

[8]  Richard C. Laughlin,et al.  Cellular and molecular mechanisms that underlie Entamoeba histolytica pathogenesis: prospects for intervention , 2005, Expert Reviews in Molecular Medicine.

[9]  L. Lettice,et al.  Preaxial polydactyly: a model for defective long-range regulation in congenital abnormalities. , 2005, Current opinion in genetics & development.

[10]  Honglin Jiang,et al.  Identification of a Distal STAT5-binding DNA Region That May Mediate Growth Hormone Regulation of Insulin-like Growth Factor-I Gene Expression* , 2005, Journal of Biological Chemistry.

[11]  P. Ramakrishnan,et al.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Granados,et al.  Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. , 2005, Journal of autoimmunity.

[13]  A. Reymond,et al.  Conserved non-genic sequences — an unexpected feature of mammalian genomes , 2005, Nature Reviews Genetics.

[14]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[15]  A. Barton,et al.  A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. , 2004, Arthritis and rheumatism.

[16]  C. Ware,et al.  TNF Receptor-Associated Factor 5 Limits the Induction of Th2 Immune Responses1 , 2004, The Journal of Immunology.

[17]  A. Barton,et al.  Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[18]  A. Silman,et al.  Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis , 2004, Annals of the rheumatic diseases.

[19]  G. Cheng,et al.  The signaling adaptors and pathways activated by TNF superfamily. , 2003, Cytokine & growth factor reviews.

[20]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[21]  Naoto Endo,et al.  Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Paul Wordsworth,et al.  Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. , 2002, Arthritis and rheumatism.

[23]  Chia-Hui Lin,et al.  Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. , 2001, The Journal of rheumatology.

[24]  T. Huizinga,et al.  Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. , 2001, Cytokine.

[25]  F. Breedveld,et al.  Allele-specific quantification of tumor necrosis factor α (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals , 2001, Genes and Immunity.

[26]  C I Amos,et al.  A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. , 2001, American journal of human genetics.

[27]  D. Hartl,et al.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. , 1998, Tissue antigens.

[28]  G. Gyapay,et al.  New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Belaiche,et al.  Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans , 1998, Clinical and experimental immunology.

[30]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[32]  A. Silman,et al.  A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. , 1994, The Journal of rheumatology.

[33]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[34]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[35]  J. Lacki,et al.  TNF-α gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis , 2000, Rheumatology International.

[36]  L. Abraham,et al.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. , 1997, Molecular immunology.

[37]  E. Pareja,et al.  Polymorphism at the TNF loci in rheumatoid arthritis. , 1997, Tissue antigens.

[38]  D. Grennan,et al.  Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. , 1995, Disease markers.